Qpex Biopharma
San Diego, US · Founded 2018 · 36 employees on LinkedIn · 3 known investors
QpexBio develops anti-infective drugs designed to overcome multidrug resistance, improving existing drug classes and discovering new ones for use in combination with known anti-infectives against drug-resistant bacteria. The company operates R&D laboratories in San Diego, California, working alongside Shionogi's research labs in Japan.
Founders & leadership
Qpex Biopharma was founded in 2018 by Michael N. Dudley.
MN
Michael N. DudleyFounder
TG
Terry GouldNamed on SEC filing
DB
Daniel BurgessNamed on SEC filing
Board
CG
Carol GallagherBoard director
DR
Douglas ReedBoard director
KL
Kevin LiBoard director
Investors · 3
Reported raises · per SEC filings
Form D private placements$27.4M disclosed across 1 round · 2018
▶$27.4MraisedAug 2019 · 11 investors · BiotechnologyRule 506(b)
▶$27.4MraisedAug 2019 · 11 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael N. DudleyExecutive Officer, Director
- Carol GallagherDirector
- Terry GouldDirector
- Douglas ReedDirector
- Kevin LiDirector
- Daniel BurgessDirector
- Offering amount
- $41.1M
- Amount sold
- $27.4M
- First sale
- Oct 2018
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlap
IQVIA14 shared keywordsIQVIA provides data, analytics, AI, and technology-driven services for life sciences and healthcare organizations, spanning clinical development, real world evidence generation, and commercial execution. It offers integrated solutions for clinical trials, regulatory and safety compliance, and market analytics, including agentic AI products for commercial and R&D teams.
Bioworld12 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Companies competing with Qpex Biopharma for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Qpex Biopharma do?
- QpexBio develops anti-infective drugs designed to overcome multidrug resistance, improving existing drug classes and discovering new ones for use in combination with known anti-infectives against drug-resistant bacteria. The company operates R&D laboratories in San Diego, California, working alongside Shionogi's research labs in Japan.
- Who founded Qpex Biopharma?
- Qpex Biopharma was founded by Michael N. Dudley in 2018.
- Who are Qpex Biopharma's investors?
- Qpex Biopharma's investors include Hatteras Venture Partners, LYZZ Capital, New Enterprise Associates (NEA).
- How much funding has Qpex Biopharma raised?
- Qpex Biopharma has disclosed $27.4M raised across 1 round.
- Where is Qpex Biopharma headquartered?
- Qpex Biopharma is headquartered in San Diego, US.